Canada markets closed

Teva Pharmaceutical Industries Limited (TEVA.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA (0.01 ILS)
Add to watchlist
5,207.00+61.00 (+1.19%)
At close: 05:24PM IDT
Currency in ILA

Valuation Measures4

Market Cap (intraday) 58.29B
Enterprise Value 121.21B
Trailing P/E 921.38
Forward P/E 5.82
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.98
Price/Book (mrq)2.09
Enterprise Value/Revenue 7.65
Enterprise Value/EBITDA 77.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 356.84%
S&P500 52-Week Change 322.38%
52 Week High 35,379.00
52 Week Low 32,637.00
50-Day Moving Average 34,991.22
200-Day Moving Average 34,104.73

Share Statistics

Avg Vol (3 month) 31.38M
Avg Vol (10 day) 32.78M
Shares Outstanding 51.13B
Implied Shares Outstanding 61.14B
Float 81.11B
% Held by Insiders 10.56%
% Held by Institutions 18.97%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 42.96
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 28, 2017
Last Split Factor 22:1
Last Split Date 3Jun 27, 2004

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -3.53%
Operating Margin (ttm)28.05%

Management Effectiveness

Return on Assets (ttm)4.54%
Return on Equity (ttm)-7.36%

Income Statement

Revenue (ttm)15.85B
Revenue Per Share (ttm)14.16
Quarterly Revenue Growth (yoy)14.80%
Gross Profit (ttm)N/A
EBITDA 4.33B
Net Income Avi to Common (ttm)-559M
Diluted EPS (ttm)-1.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.23B
Total Cash Per Share (mrq)2.88
Total Debt (mrq)20.27B
Total Debt/Equity (mrq)249.48%
Current Ratio (mrq)1.02
Book Value Per Share (mrq)6.70

Cash Flow Statement

Operating Cash Flow (ttm)1.37B
Levered Free Cash Flow (ttm)3.29B